Cellectis (CLLS) EBITDA Margin Growth (1y) (2016 - 2026)
Cellectis (CLLS) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | -30,257.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30,257.00 |
| Dec 31, 2025 | -5,247.00 |
| Sep 30, 2025 | 8,934.00 |
| Jun 30, 2025 | 15,619.00 |
| Mar 31, 2025 | 32,837.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | -1.04 Mn |
| Sep 30, 2023 | 229,416.00 |
| Jun 30, 2023 | -1.12 Mn |
| Mar 31, 2023 | -1.51 Mn |
| Dec 31, 2022 | 20,401.00 |
| Sep 30, 2022 | -1.51 Mn |
| Jun 30, 2022 | -175,438.00 |
| Mar 31, 2022 | -167,768.00 |
| Dec 31, 2021 | 4,761.00 |
| Sep 30, 2021 | -3,468.00 |
| Jun 30, 2021 | 80,363.00 |